Shortage of Chemotherapy Drugs Brings Rationing Fears for Cancer Patients
Doctors treating cancer patients nationwide are facing a shortage of essential generic chemotherapy drugs, a situation that many…
Magnesium Recall: FDA Announces Popular Supplement’s Removal
Along with vitamin D, magnesium became one of those supplements that grew massively in popularity starting around the…
Thousands of Bottles of Blood Pressure Medication Recalled Nationwide
“Hearst Magazines and Yahoo may earn commission or revenue on some items through these links.” The Food and…
Antidepressant Used by Millions Recalled Over Possible Cancer-Causing Contamination
Millions of Americans who take a popular antidepressant are being urged to check their medicine cabinets after a…
Antidepressant Used by Millions Recalled Over Contamination Fears
Millions of Americans who take a popular antidepressant are being urged to check their medicine cabinets after a…
Antidepressant recalled due to presence of potentially cancer-causing impurity
Thousands of bottles of the antidepressant duloxetine have been recalled because they contain levels of a potentially cancer-causing…
New Weight Loss Drug Could Beat Ozempic’s Results—When It’s Coming
A new experimental weight loss drug from Eli Lilly could produce greater weight loss results than popular medications…
FDA launches safety study for abortion pill mifepristone, source says
The Food and Drug Administration has launched a safety study of the abortion pill mifepristone, a senior FDA…
Supplement Recalled Over ‘Fatal Physiological’ Risks
A popular dietary supplement is being pulled from the market after the U.S. Food and Drug Administration (FDA)…
25,000 Herbal Supplement Products Recalled Nationwide
In the past two months, cautions have been noted surrounding multiple herbal supplements—one report for a study that…
Cingulate Receives Complete Response Letter from FDA for CTx-1301
Cingulate Inc. No Clinical Safety or Efficacy Concerns Currently Identified Agency Feedback Primarily Focused on CMC-Related RequestsCompany Plans Prompt…
US FDA declines to approve Cingulate’s ADHD drug
June 2 (Reuters) – Cingulate said on Tuesday that the U.S. Food and Drug Administration declined to approve…